DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION
发明人:
KANG, TAE HONG,강태홍,KANG, TAE HONGKR
申请号：
KR1020150108209
公开号：
KR1016922460000B1
申请日:
2015.07.30
申请国别(地区):
KR
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition for treating lung cancer. The pharmaceutical composition contains a lung cancer treatment agent and a sirtuin 1 (SIRT1) inhibitor and minimizes tolerance to the lung cancer treatment agent in lung cancer cells, thereby exhibiting outstanding efficacy of treating lung cancer.폐암 치료제 및 SIRT1 저해제를 포함함으로써, 폐암 세포의 폐암 치료제에 대한 내성 발현을 최소화하여, 폐암 치료 효능이 우수한 폐암 치료용 의약 조성물에 관한 것이다.
